SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Bio-Rad Labs: Things are changing -- Ignore unavailable to you. Want to Upgrade?


To: Dave Chanoux who wrote (12)3/5/2000 10:29:00 PM
From: Dave Chanoux  Respond to of 18
 
Back to distributing the news. Here is an interesting item covering intellectual property.

biz.yahoo.com

Bio-Rad Laboratories Wins Patent Suit for HIV-2 Test Against Singapore-Based Genelabs Diagnostics Pte. Ltd.

MARNES-LA-COQUETTE, France, March 3 /PRNewswire/ -- Bio-Rad Laboratories, Inc. announced today that a patent infringement lawsuit concerning production of a diagnostic test for HIV-2 was decided in its favor.

Interesting demonstration of: worldwide scope of the activity, strength of the intellectual property, financial reward (unspecified), local of the decision, source (PSD) and timeliness of the product.

Regards,

Dave Chanoux



To: Dave Chanoux who wrote (12)3/24/2000 11:27:00 AM
From: Hamilton Rogers  Read Replies (1) | Respond to of 18
 
You may be interested in some of the new technology which Bio-Rad is now using. Luminex is an IPO coming out next Tuesday the 28th by Warburg Dillon Read. The prospectus mentions Bio-Rad Labs as a customer of theirs. I started a thread in the IPO category for Luminex here on SI.

Check out their website: luminexcorp.com